SGHT earnings date and last-quarter result: next report 2026-08-06, last quarter beat, P/E -7.10. Updated 2026-07-23.
Sight Sciences (SGHT) Research Hub
Sight Sciences (SGHT) trades on NASDAQ, US in the Healthcare (Medical - Devices) sector. As of 2026-10-26, shares last closed at 9.02 USD (+0.33%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -7.10, market cap 0.27B. This hub links to the full technical, earnings and options research available for SGHT.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Devices) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 9.02 USD (+0.33%) |
| 52-week range | 4.41 USD – 9.71 USD |
| Trend regime | Range |
| 14-day RSI | 56.8 (Bullish) |
| Trailing P/E | -7.10 |
| Market cap | 0.27B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-06 |
Available research for SGHT
Covered Call on SGHT: how it works, illustrative setup around the real 9.02 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on SGHT: how it works, illustrative setup around the real 9.02 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on SGHT: how it works, illustrative setup around the real 9.02 USD price, max profit/loss, breakeven and when to use it. Educational.
SGHT technical analysis: range, last 9.02 USD, RSI 56.8, 52w range 4.41 USD–9.71 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is SGHT in?
Sight Sciences (SGHT) is classified under Healthcare (Medical - Devices), listed on NASDAQ, US.
Is SGHT in an uptrend or downtrend?
As of 2026-10-26, SGHT is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is SGHT's trailing P/E ratio?
SGHT's trailing P/E is -7.10, with a market cap of 0.27B. See the earnings research page for full valuation detail.
When does SGHT next report earnings?
SGHT is next scheduled to report earnings on 2026-08-06.